Table 6.
Adverse events.
| All (n=91) | ||
|---|---|---|
| Symptoms | Any grade | Grade 3-4 |
| Any adverse event | 88 (96.7%) | 22 (24.2%) |
| Fatigue | 10 (11.0%) | 1 (1.1%) |
| Hypertension | 30 (33.0%) | 4 (4.4%) |
| Decreased appetite | 23 (25.3%) | 3 (3.3%) |
| Diarrhea | 12 (13.1%) | 4 (4.4%) |
| Hypothyroidism | 4 (4.4%) | 0 |
| Proteinuria | 3 (3.3%) | 0 |
| Dysphonia | 2 (2.2%) | 0 |
| Epistaxis | 2 (2.2%) | 0 |
| Fever | 5 (5.5%) | 0 |
| Edema | 3 (3.3%) | 0 |
| Cramps | 3 (3.3%) | 0 |
| Nausea | 13 (14.3%) | 0 |
| Vomiting | 6 (6.6%) | 0 |
| Pneumonia | 1 (1.1%) | 0 |
| Abdominal distension | 2 (2.2%) | 0 |
| Hand-foot skin reaction | 3 (3.3%) | 0 |
| Increased blood bilirubin | 22 (24.2%) | 4 (4.4%) |
| Rash | 6 (6.6%) | 0 |
| Abdominal pain | 2 (2.2%) | 0 |
| Increased creatinine | 1 (1.1%) | 0 |
| ALT elevation | 24 (26.4%) | 0 |
| AST elevation | 47 (51.6%) | 6 (6.6%) |
ALT, alanine transaminase; AST, aspartate aminotransferase.